Omnicell Announces Changes to Its Board of Directors - Seite 2

“I am excited for the opportunity to join the Omnicell Board of Directors at such a critical time for healthcare,” said Ms. Garrett. “I have always been passionate about the healthcare technology space and believe Omnicell is uniquely positioned to deliver improved patient outcomes through automating manual medication management processes. I look forward to the chance to collaborate with Omnicell’s directors and management team to help the Company achieve its goals.”

Company’s Chief Legal and Administrative Officer Retiring

The Company also announced today that Dan S. Johnston will be retiring as Executive Vice President and Chief Legal and Administrative Officer, effective June 30, 2022.

Mr. Lipps said, “I would like to thank Dan for his sound counsel and service over nearly two decades with Omnicell. He consistently provided the expertise we needed to grow Omnicell into the successful company we are today. I am grateful for his commitment to our organization and wish him well in his well-earned retirement.”

Forward-Looking Statements

To the extent any statements contained in this press release deal with information that is not historical, these statements are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, statements including the words “expect,” “intend,” “may,” “will,” “should,” “would,” “could,” “plan,” “potential,” “anticipate,” “believe,” “forecast,” “guidance,” “outlook,” “goals,” “target,” “estimate,” “seek,” “predict,” “project,” and similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to the occurrence of many events outside Omnicell’s control. Such statements include, but are not limited to, statements about Omnicell’s strategy, plans, objectives, goals, and vision, and Omnicell’s expectations regarding the announced planned director nomination and expectations regarding filling the vacancy on the board of directors. Actual results and other events may differ significantly from those contemplated by forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the risk that the announced planned nomination is not satisfactory and election is unsuccessful; the identified nominee is negatively viewed by investors and subsequently impacts the perception of Omnicell and/or its board of directors and the value of Omnicell’s common stock, and the other risks and uncertainties further described in the “Risk Factors” section of Omnicell’s most recent Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as in Omnicell’s other reports filed with or furnished to the United States Securities and Exchange Commission, available at www.sec.gov. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. Omnicell assumes no obligation to update any such statements publicly, or to update the reasons actual results could differ materially from those expressed or implied in any forward-looking statements, whether as a result of changed circumstances, new information, future events, or otherwise, except as required by law.